ASX:NEUPharmaceuticals
Neuren Pharmaceuticals First Half 2025 Earnings: EPS Beats Expectations, Revenues Lag
Neuren Pharmaceuticals ( ASX:NEU ) First Half 2025 Results Key Financial Results Revenue: AU$28.3m (up 7.7% from 1H...
Stock Analysis
Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.